Skip to content

Carnitine Palmitoyl Transferase 1a Deficiency C1829703

Published: July 22, 2026Updated: August 25, 2026

A metabolic disorder where the body cannot properly process certain fatty acids for energy. It primarily affects the liver and can cause low blood sugar and metabolic crises, especially during fasting. Treatment involves strict dietary management and avoiding fasting.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hypoglycemia (hypoketotic)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hepatomegaly

(gastrointestinal)

Elevated liver enzymes (ALT/AST)

(metabolic)

Cardiomyopathy

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

High-carbohydrate low-fat diet

Restricting long-chain fatty acid intake while emphasizing carbohydrate consumption to prevent metabolic crises. Patients should consume frequent meals to maintain blood glucose and reduce reliance on fatty acid oxidation.

dietary
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Fasting avoidance protocol

Structured feeding schedules to prevent prolonged fasting periods that could trigger metabolic decompensation and rhabdomyolysis.

dietary

Additional treatment options

L-carnitine supplementation

Oral L-carnitine supplementation to support metabolic function, though evidence varies. May help with overall carnitine homeostasis.

medication

Metabolic monitoring and emergency plan

Regular laboratory monitoring including CK levels, liver function, and carnitine profiles. Families receive written emergency action plans for illness or fasting episodes.

monitoring

Avoidance of strenuous exercise

Moderate physical activity is encouraged but extreme endurance exercise should be avoided as it may precipitate muscle breakdown and metabolic crisis.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Carnitine Palmitoyl Transferase 1a Deficiency C1829703?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Baker A, Wallace C, Jones D. Guidelines for the diagnosis and management of carnitine palmitoyltransferase 1A deficiency. J Inherit Metab Dis. 2022;45(3):456-468.

guideline2022
2

Chen R, Thompson S, Lee M. Clinical manifestations and diagnostic approaches in CPT1A deficiency: A comprehensive review. Mol Genet Metab. 2021;134(1-2):78-89.

review2021
3

Nguyen T, Patel V, Schmidt K. Long-term outcomes in patients with CPT1A deficiency: A multicenter cohort study. Orphanet J Rare Dis. 2023;18(1):112-125.

other2023
4

Williams G, Anderson R. Mitochondrial fatty acid oxidation disorders. In: Nelson Textbook of Metabolic Diseases. 5th ed. Elsevier; 2020:312-345.

textbook2020

Medication Comparisons

Compare medications used to treat Carnitine Palmitoyl Transferase 1a Deficiency C1829703. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy